0001209191-19-043329.txt : 20190726 0001209191-19-043329.hdr.sgml : 20190726 20190726161352 ACCESSION NUMBER: 0001209191-19-043329 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20190724 FILED AS OF DATE: 20190726 DATE AS OF CHANGE: 20190726 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Baxter Joel D. CENTRAL INDEX KEY: 0001666161 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-04851 FILM NUMBER: 19978219 MAIL ADDRESS: STREET 1: 101 W. PROSPECT AVENUE CITY: CLEVELAND STATE: OH ZIP: 44115 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SHERWIN WILLIAMS CO CENTRAL INDEX KEY: 0000089800 STANDARD INDUSTRIAL CLASSIFICATION: RETAIL-BUILDING MATERIALS, HARDWARE, GARDEN SUPPLY [5200] IRS NUMBER: 340526850 STATE OF INCORPORATION: OH FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 101 PROSPECT AVE NW CITY: CLEVELAND STATE: OH ZIP: 44115 BUSINESS PHONE: 2165662200 MAIL ADDRESS: STREET 1: 101 PROSPECT AVE NW CITY: CLEVELAND STATE: OH ZIP: 44115 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-07-24 0 0000089800 SHERWIN WILLIAMS CO SHW 0001666161 Baxter Joel D. 101 W. PROSPECT AVENUE CLEVELAND OH 44115 0 1 0 0 Pres. & GM, Glob. Supply Chain Common Stock 2019-07-24 4 M 0 6083 239.55 A 8216 D Common Stock 2019-07-24 4 S 0 600 489.34 D 7616 D Common Stock 2019-07-24 4 S 0 400 490.61 D 7216 D Common Stock 2019-07-24 4 S 0 2780 492.36 D 4436 D Common Stock 2019-07-24 4 S 0 2098 493.07 D 2338 D Common Stock 2019-07-24 4 S 0 205 495.21 D 2133 D Common Stock 7209.4 I Stock Plan Employee Stock Option (Right to Buy) 239.55 2019-07-24 4 M 0 2167 0.00 D 2016-10-16 2025-10-15 Common Stock 2167 0 D Employee Stock Option (Right to Buy) 239.55 2019-07-24 4 M 0 2167 0.00 D 2017-10-16 2025-10-15 Common Stock 2167 0 D Employee Stock Option (Right to Buy) 239.55 2019-07-24 4 M 0 1749 0.00 D 2018-10-16 2025-10-15 Common Stock 1749 0 D The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $489.24 to $489.84 inclusive. The reporting person undertakes to provide to The Sherwin-Williams Company, any security holder of The Sherwin-Williams Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $490.55 to $490.67 inclusive. The reporting person undertakes to provide to The Sherwin-Williams Company, any security holder of The Sherwin-Williams Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $491.77 to $492.76 inclusive. The reporting person undertakes to provide to The Sherwin-Williams Company, any security holder of The Sherwin-Williams Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $492.84 to $493.35 inclusive. The reporting person undertakes to provide to The Sherwin-Williams Company, any security holder of The Sherwin-Williams Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $494.93 to $495.48 inclusive. The reporting person undertakes to provide to The Sherwin-Williams Company, any security holder of The Sherwin-Williams Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. Of shares listed, 1,277 are restricted stock units. Represents the number of shares of common stock attributable to the reporting person's participation in The Sherwin-Williams Company Employee Stock Purchase and Savings Plan per the trustee's 06/30/2019 statement. Exhibit 24, Power of Attorney, is attached. Stephen J. Perisutti, Attorney-in-fact 2019-07-26 EX-24.4_866124 2 poa.txt POA DOCUMENT POWER OF ATTORNEY Know all by these presents, that the undersigned hereby constitutes and appoints each of John G. Morikis, Allen J. Mistysyn, Mary L. Garceau and Stephen J. Perisutti, or any of them signing singly, and with full power of substitution, as the undersigned's true and lawful attorney-in-fact to: (1) prepare, execute in the undersigned's name and on the undersigned's behalf, and submit to the U.S. Securities and Exchange Commission (the "SEC") a Form ID, including amendments thereto, and any other documents necessary or appropriate to obtain codes and passwords enabling the undersigned to make electronic filings with the SEC of reports required by Section 16(a) of the Securities Exchange Act of 1934 or any rule or regulation of the SEC ("Section 16"); (2) execute for and on behalf of the undersigned, in the undersigned's capacity as an officer and/or director of The Sherwin-Williams Company (the "Company"), Forms 3, 4, and 5 in accordance with Section 16; (3) do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete and execute any such Form 3, 4, or 5, complete and execute any amendment or amendments thereto, and timely file any such form with the SEC and any stock exchange or similar authority; and (4) take any other action of any type whatsoever in connection with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit to, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney in fact may approve in such attorney-in-fact's discretion. The undersigned hereby grants to each such attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary, or desirable to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney-in-fact, or such attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be done by virtue of this Power of Attorney and the rights and powers herein granted. The undersigned acknowledges that the foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned, are not assuming, nor is the Company assuming, any of the undersigned's responsibilities to comply with Section 16. This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4, and 5 with respect to the undersigned's holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to the foregoing attorneys-in-fact. IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of this 22nd day of July, 2019. /s/ Joel D. Baxter